Does LOVASTATIN Cause Hyperbilirubinaemia? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperbilirubinaemia have been filed in association with LOVASTATIN (Lovastatin). This represents 0.8% of all adverse event reports for LOVASTATIN.
11
Reports of Hyperbilirubinaemia with LOVASTATIN
0.8%
of all LOVASTATIN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From LOVASTATIN?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOVASTATIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does LOVASTATIN Cause?
Drug hypersensitivity (217)
Myalgia (192)
Drug ineffective (137)
Completed suicide (91)
Muscle spasms (91)
Cerebrovascular accident (81)
Myocardial infarction (71)
Asthenia (67)
Arthralgia (63)
Disease progression (59)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which LOVASTATIN Alternatives Have Lower Hyperbilirubinaemia Risk?
LOVASTATIN vs LOVAZA
LOVASTATIN vs LOVENOX
LOVASTATIN vs LOXAPINE
LOVASTATIN vs LOXOPROFEN
LOVASTATIN vs LUBIPROSTONE